{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:15:27Z","timestamp":1793042127266,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]},{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]},{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]},{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]},{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]},{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]},{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]},{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]},{"name":"the Jiangyin Municipal Health Commission Research Project","award":["M202316"],"award-info":[{"award-number":["M202316"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10495-025-02243-5","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:57:50Z","timestamp":1772549870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["M2pep-modified liposomal nanoparticles delivering siITGB4 induce apoptosis and inhibit NSCLC metastasis via macrophage reprogramming"],"prefix":"10.1007","volume":"31","author":[{"given":"Xiaofeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedong","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2243_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"2243_CR2","doi-asserted-by":"crossref","unstructured":"Tian Y, Ma R, Zhao W et al (2025) Comprehensive characterization of early-onset lung cancer, in Chinese young adults. Nat Commun 16","DOI":"10.1038\/s41467-025-57309-4"},{"key":"2243_CR3","unstructured":"WAN N, WANG B, GUO Y et al (2024) Real-world study of the safety and efficacy of pembrolizumab in the treatment of advanced Non-small cell lung cancer. Chin J Lung Cancer 27"},{"key":"2243_CR4","doi-asserted-by":"crossref","unstructured":"B\u00edlek O, Selingerov\u00e1 I, Kysela M et al (2024) Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic \u2013 data from Masaryk memorial cancer Institute registry in 2018\u20132022. Klin Onkol 37","DOI":"10.48095\/ccko2024433"},{"key":"2243_CR5","doi-asserted-by":"crossref","unstructured":"Su P-L, Furuya N, Asrar A et al (2025) Recent advances in therapeutic strategies for non-small cell lung cancer. J Hematol Oncol 18","DOI":"10.1186\/s13045-025-01679-1"},{"key":"2243_CR6","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753","journal-title":"Pharmacol Ther"},{"key":"2243_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41:374\u2013403","journal-title":"Cancer Cell"},{"key":"2243_CR8","first-page":"3855","volume":"22","author":"JJ Wang","year":"2018","unstructured":"Wang JJ, Lei KF, Han FJ (2018) Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci 22:3855\u20133864","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2243_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","volume":"43","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhou Z, Du X et al (2025) Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion. Cancer Cell 43:1045\u20131060e7","journal-title":"Cancer Cell"},{"key":"2243_CR10","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.immuni.2024.08.015","volume":"57","author":"Z Nian","year":"2024","unstructured":"Nian Z, Dou Y, Shen Y et al (2024) Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation. Immunity 57:2344\u20132361e7","journal-title":"Immunity"},{"key":"2243_CR11","doi-asserted-by":"crossref","unstructured":"Gao J, Liang Y, Wang L (2022) Shaping polarization of Tumor-Associated macrophages in cancer immunotherapy. Front Immunol 13","DOI":"10.3389\/fimmu.2022.888713"},{"key":"2243_CR12","doi-asserted-by":"publisher","first-page":"121137","DOI":"10.1016\/j.biomaterials.2021.121137","volume":"278","author":"GR Gunassekaran","year":"2021","unstructured":"Gunassekaran GR, Poongkavithai Vadevoo SM, Baek M-C, Lee B (2021) M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages. Biomaterials 278:121137","journal-title":"Biomaterials"},{"key":"2243_CR13","doi-asserted-by":"publisher","first-page":"104284","DOI":"10.1016\/j.critrevonc.2024.104284","volume":"196","author":"Z Huang","year":"2024","unstructured":"Huang Z, Xiao Z, Yu L et al (2024) Tumor-associated macrophages in non-small-cell lung cancer: from treatment resistance mechanisms to therapeutic targets. Crit Rev Oncol\/Hematol 196:104284","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"2243_CR14","doi-asserted-by":"publisher","first-page":"116014","DOI":"10.1016\/j.biopha.2023.116014","volume":"170","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Qian M, Li J et al (2024) The role of tumor-associated macrophages in lung cancer: from mechanism to small molecule therapy. Biomed Pharmacother 170:116014","journal-title":"Biomed Pharmacother"},{"key":"2243_CR15","doi-asserted-by":"crossref","unstructured":"Kerneur C, Cano CE, Olive D (2022) Major pathways involved in macrophage polarization in cancer. Front Immunol 13","DOI":"10.3389\/fimmu.2022.1026954"},{"key":"2243_CR16","doi-asserted-by":"crossref","unstructured":"Zheng J, Jiang J, Pu Y et al (2023) Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms. Front Bioeng Biotechnol 11","DOI":"10.3389\/fbioe.2023.1248421"},{"key":"2243_CR17","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1021\/acsabm.1c00461","volume":"4","author":"X Lin","year":"2021","unstructured":"Lin X, Fang Y, Jin X et al (2021) Modulating repolarization of Tumor-Associated macrophages with targeted therapeutic nanoparticles as a potential strategy for cancer therapy. ACS Appl Bio Mater 4:5871\u20135896","journal-title":"ACS Appl Bio Mater"},{"key":"2243_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1021\/acsbiomaterials.3c01595","volume":"10","author":"DC J\u00fcrgens","year":"2023","unstructured":"J\u00fcrgens DC, Winkeljann B, Kolog Gulko M et al (2023) Efficient and targeted SiRNA delivery to M2 macrophages by smart polymer blends for M1 macrophage repolarization as a promising strategy for future cancer treatment. ACS Biomater Sci Eng 10:166\u2013177","journal-title":"ACS Biomater Sci Eng"},{"key":"2243_CR19","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1021\/acs.molpharmaceut.2c00977","volume":"20","author":"CC Parker","year":"2023","unstructured":"Parker CC, Bin Salam A, Song PN et al (2023) Evaluation of a CD206-Targeted peptide for PET imaging of macrophages in syngeneic mouse models of cancer. Mol Pharm 20:2415\u20132425","journal-title":"Mol Pharm"},{"key":"2243_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s12033-024-01061-5","volume":"67","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu C, Liu D et al (2024) Integrin \u03b24 regulates cell migration of lung adenocarcinoma through FAK signaling. Mol Biotechnol 67:496\u2013509","journal-title":"Mol Biotechnol"},{"key":"2243_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1158\/0008-5472.CAN-19-1145","volume":"80","author":"S Ruan","year":"2020","unstructured":"Ruan S, Lin M, Zhu Y et al (2020) Integrin \u03b24\u2013Targeted cancer immunotherapies inhibit tumor growth and decrease metastasis. Cancer Res 80:771\u2013783","journal-title":"Cancer Res"},{"key":"2243_CR22","doi-asserted-by":"publisher","first-page":"101116","DOI":"10.1016\/j.redox.2019.101116","volume":"22","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li H, Wu Q et al (2019) Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS\/PI3K signaling-dependent various cytokine production to promote NSCLC growth. Redox Biol 22:101116","journal-title":"Redox Biol"},{"key":"2243_CR23","doi-asserted-by":"crossref","unstructured":"Yuan R, Fan Q, Liang X et al (2022) Cucurbitacin B inhibits TGF-\u03b21-induced epithelial\u2013mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K\/Akt\/mTOR pathways. Chin Med 17","DOI":"10.1186\/s13020-022-00581-z"},{"key":"2243_CR24","doi-asserted-by":"publisher","first-page":"101826","DOI":"10.1016\/j.mtbio.2025.101826","volume":"32","author":"Z Hussain","year":"2025","unstructured":"Hussain Z, Gou S, Liu X et al (2025) Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47\/Sirp\u03b1 pathway. Mater Today Bio 32:101826","journal-title":"Mater Today Bio"},{"key":"2243_CR25","doi-asserted-by":"publisher","first-page":"113564","DOI":"10.1016\/j.intimp.2024.113564","volume":"144","author":"X Huang","year":"2025","unstructured":"Huang X, Yu G, Jiang X et al (2025) ITGB4\/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis. Int Immunopharmacol 144:113564","journal-title":"Int Immunopharmacol"},{"key":"2243_CR26","doi-asserted-by":"publisher","first-page":"101272","DOI":"10.1016\/j.drup.2025.101272","volume":"82","author":"W Ding","year":"2025","unstructured":"Ding W, Mo J, Su Y et al (2025) Metabolic reprogramming of tumor-associated macrophages via adenosine-A2AR signaling drives cross-resistance in non-small cell lung cancer. Drug Resist Updates 82:101272","journal-title":"Drug Resist Updates"},{"key":"2243_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.apsb.2022.10.004","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Hai L, Gao Y et al (2023) Lipid nanomaterials-based RNA therapy and cancer treatment. Acta Pharm Sinica B 13:903\u2013915","journal-title":"Acta Pharm Sinica B"},{"key":"2243_CR28","doi-asserted-by":"crossref","unstructured":"Pang L, Pei Y, Uzunalli G et al (2019) Surface modification of polymeric nanoparticles with M2pep peptide for drug delivery to Tumor-Associated macrophages. Pharm Res 36","DOI":"10.1007\/s11095-019-2596-5"},{"key":"2243_CR29","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.7150\/thno.50928","volume":"11","author":"S Han","year":"2021","unstructured":"Han S, Wang W, Wang S et al (2021) Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes. Theranostics 11:2892\u20132916","journal-title":"Theranostics"},{"key":"2243_CR30","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.3390\/pharmaceutics14112511","volume":"14","author":"M Huang","year":"2022","unstructured":"Huang M, Wang R, Li M et al (2022) Peptide-Based [68Ga]Ga labeled PET tracer for tumor imaging by targeting tumor-Associated macrophages. Pharmaceutics 14:2511","journal-title":"Pharmaceutics"},{"key":"2243_CR31","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s12094-024-03527-z","volume":"26","author":"J Zhang","year":"2024","unstructured":"Zhang J, Li L, Luo W et al (2024) ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis. Clin Transl Oncol 26:2979\u20132992","journal-title":"Clin Transl Oncol"},{"key":"2243_CR32","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.4103\/jcrt.jcrt_230_24","volume":"20","author":"F Cong","year":"2024","unstructured":"Cong F, Huang J, Wu C et al (2024) Integrin \u03b16 and integrin \u03b24 in exosomes promote lung metastasis of colorectal cancer. J Cancer Res Ther 20:2082\u20132093","journal-title":"J Cancer Res Ther"},{"key":"2243_CR33","doi-asserted-by":"crossref","unstructured":"Li J, Hao N, Han J et al (2020) RETRACTED ARTICLE: ZKSCAN3 drives tumor metastasis via integrin \u03b24\/FAK\/AKT mediated epithelial\u2013mesenchymal transition in hepatocellular carcinoma. Cancer Cell Int 20","DOI":"10.1186\/s12935-020-01307-7"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02243-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02243-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02243-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:26:10Z","timestamp":1774985170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02243-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02243-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Jiangyin Clinical College of Xuzhou Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"78"}}